Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer

Overview of attention for article published in BMC Cancer, February 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 66 followers.

fascinating results with tenserolimus in recurrent bladder cancer https://t.co/gbGw4qgHgM https://t.co/Z0eXfGegsD

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.